These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 38380331)

  • 1. Understanding the glioblastoma tumor microenvironment: leveraging the extracellular matrix to increase immunotherapy efficacy.
    Collado J; Boland L; Ahrendsen JT; Miska J; Lee-Chang C
    Front Immunol; 2024; 15():1336476. PubMed ID: 38380331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification of Extracellular Matrix Enhances Oncolytic Adenovirus Immunotherapy in Glioblastoma.
    Kiyokawa J; Kawamura Y; Ghouse SM; Acar S; Barçın E; Martínez-Quintanilla J; Martuza RL; Alemany R; Rabkin SD; Shah K; Wakimoto H
    Clin Cancer Res; 2021 Feb; 27(3):889-902. PubMed ID: 33257429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives.
    Lin H; Liu C; Hu A; Zhang D; Yang H; Mao Y
    J Hematol Oncol; 2024 May; 17(1):31. PubMed ID: 38720342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune Escape in Glioblastoma Multiforme and the Adaptation of Immunotherapies for Treatment.
    Pearson JRD; Cuzzubbo S; McArthur S; Durrant LG; Adhikaree J; Tinsley CJ; Pockley AG; McArdle SEB
    Front Immunol; 2020; 11():582106. PubMed ID: 33178210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycomaterials to Investigate the Functional Role of Aberrant Glycosylation in Glioblastoma.
    Tondepu C; Karumbaiah L
    Adv Healthc Mater; 2022 Feb; 11(4):e2101956. PubMed ID: 34878733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glioblastoma Microenvironment and Invasiveness: New Insights and Therapeutic Targets.
    Erices JI; Bizama C; Niechi I; Uribe D; Rosales A; Fabres K; Navarro-Martínez G; Torres Á; San Martín R; Roa JC; Quezada-Monrás C
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Interplay between Glioblastoma and Its Microenvironment.
    Dapash M; Hou D; Castro B; Lee-Chang C; Lesniak MS
    Cells; 2021 Aug; 10(9):. PubMed ID: 34571905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of tumor immunity and immunotherapy by the tumor collagen extracellular matrix.
    Flies DB; Langermann S; Jensen C; Karsdal MA; Willumsen N
    Front Immunol; 2023; 14():1199513. PubMed ID: 37662958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different T-cell subsets in glioblastoma multiforme and targeted immunotherapy.
    Wang H; Zhou H; Xu J; Lu Y; Ji X; Yao Y; Chao H; Zhang J; Zhang X; Yao S; Wu Y; Wan J
    Cancer Lett; 2021 Jan; 496():134-143. PubMed ID: 33022290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic plasticity of myeloid cells in glioblastoma development, progression, and therapeutics.
    Ye Z; Ai X; Zhao L; Fei F; Wang P; Zhou S
    Oncogene; 2021 Oct; 40(42):6059-6070. PubMed ID: 34556813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune landscape-based machine-learning-assisted subclassification, prognosis, and immunotherapy prediction for glioblastoma.
    Li H; He J; Li M; Li K; Pu X; Guo Y
    Front Immunol; 2022; 13():1027631. PubMed ID: 36532035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in Nanotechnology-Based Immunotherapy for Glioblastoma.
    Tang L; Zhang M; Liu C
    Front Immunol; 2022; 13():882257. PubMed ID: 35651605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CNS and the Brain Tumor Microenvironment: Implications for Glioblastoma Immunotherapy.
    Desland FA; Hormigo A
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33027976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptome and single-cell analysis reveal the contribution of immunosuppressive microenvironment for promoting glioblastoma progression.
    Ni L; Sun P; Zhang S; Qian B; Chen X; Xiong M; Li B
    Front Immunol; 2022; 13():1051701. PubMed ID: 36685556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decipher the Glioblastoma Microenvironment: The First Milestone for New Groundbreaking Therapeutic Strategies.
    Fanelli GN; Grassini D; Ortenzi V; Pasqualetti F; Montemurro N; Perrini P; Naccarato AG; Scatena C
    Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33804731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenesis, Microenvironment Modulation and Clinical Potentiality of FAP in Glioblastoma: Lessons Learned from Other Solid Tumors.
    Shi Y; Kong Z; Liu P; Hou G; Wu J; Ma W; Cheng X; Wang Y
    Cells; 2021 May; 10(5):. PubMed ID: 34068501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extrinsic factors associated with the response to immunotherapy in glioblastoma.
    Bi H; Zhang C
    Cancer Lett; 2021 Jul; 511():47-55. PubMed ID: 33933551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain Tumor Microenvironment and Host State: Implications for Immunotherapy.
    Tomaszewski W; Sanchez-Perez L; Gajewski TF; Sampson JH
    Clin Cancer Res; 2019 Jul; 25(14):4202-4210. PubMed ID: 30804019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunosuppressive microenvironment and immunotherapy in human glioblastoma.
    Zhang X; Zhao L; Zhang H; Zhang Y; Ju H; Wang X; Ren H; Zhu X; Dong Y
    Front Immunol; 2022; 13():1003651. PubMed ID: 36466873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular vesicles in the glioblastoma microenvironment: A diagnostic and therapeutic perspective.
    Russo MN; Whaley LA; Norton ES; Zarco N; Guerrero-Cázares H
    Mol Aspects Med; 2023 Jun; 91():101167. PubMed ID: 36577547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.